Beijing Scitop Bio Tech Co Ltd (300858) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Beijing Scitop Bio Tech Co Ltd (300858) has a cash flow conversion efficiency ratio of 0.024x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥44.72 Million ≈ $6.54 Million USD) by net assets (CN¥1.83 Billion ≈ $267.24 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see Beijing Scitop Bio Tech Co Ltd (300858) total market value for the company's overall valuation and market capitalisation.
Beijing Scitop Bio Tech Co Ltd - Cash Flow Conversion Efficiency Trend (2015–2025)
This chart illustrates how Beijing Scitop Bio Tech Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.
Beijing Scitop Bio Tech Co Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Beijing Scitop Bio Tech Co Ltd ranked by their cash flow conversion efficiency. Explore cash flow quality index of Beijing Scitop Bio Tech Co Ltd to measure how well operating cash flow supports reported net income.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Guangdong Eastone Century Technology Co Ltd
SHE:300310
|
-0.086x |
|
Vulcan Steel Ltd
AU:VSL
|
0.138x |
|
Cheng Du Sheng Nuo Biotec Co. Ltd. A
SHG:688117
|
-0.021x |
|
Soulbrain Holdings Co. Ltd
KQ:036830
|
0.005x |
|
Guaranty Bancshares, Inc.
NYSE:GNTY
|
0.021x |
|
Universal Health Realty Income Trust
NYSE:UHT
|
0.086x |
|
Stark Technology Inc
TW:2480
|
0.235x |
|
Heren Health Co Ltd
SHE:300550
|
0.006x |
Annual Cash Flow Conversion Efficiency for Beijing Scitop Bio Tech Co Ltd (2015–2025)
The table below shows the annual cash flow conversion efficiency of Beijing Scitop Bio Tech Co Ltd from 2015 to 2025. View Beijing Scitop Bio Tech Co Ltd stock quote for real-time trading data and today's change.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | CN¥1.84 Billion ≈ $269.66 Million |
CN¥123.44 Million ≈ $18.06 Million |
0.067x | -15.65% |
| 2024-12-31 | CN¥1.79 Billion ≈ $261.87 Million |
CN¥142.11 Million ≈ $20.80 Million |
0.079x | +28.30% |
| 2023-12-31 | CN¥1.73 Billion ≈ $253.59 Million |
CN¥107.27 Million ≈ $15.70 Million |
0.062x | -29.26% |
| 2022-12-31 | CN¥1.70 Billion ≈ $248.26 Million |
CN¥148.46 Million ≈ $21.72 Million |
0.088x | -23.23% |
| 2021-12-31 | CN¥967.40 Million ≈ $141.56 Million |
CN¥110.27 Million ≈ $16.14 Million |
0.114x | +59.44% |
| 2020-12-31 | CN¥932.59 Million ≈ $136.47 Million |
CN¥66.67 Million ≈ $9.76 Million |
0.071x | -70.91% |
| 2019-12-31 | CN¥399.83 Million ≈ $58.51 Million |
CN¥98.27 Million ≈ $14.38 Million |
0.246x | -17.16% |
| 2018-12-31 | CN¥301.83 Million ≈ $44.17 Million |
CN¥89.55 Million ≈ $13.10 Million |
0.297x | -0.72% |
| 2017-12-31 | CN¥281.09 Million ≈ $41.13 Million |
CN¥84.00 Million ≈ $12.29 Million |
0.299x | +77.64% |
| 2016-12-31 | CN¥194.57 Million ≈ $28.47 Million |
CN¥32.73 Million ≈ $4.79 Million |
0.168x | +229.95% |
| 2015-12-31 | CN¥52.67 Million ≈ $7.71 Million |
CN¥2.69 Million ≈ $392.95K |
0.051x | -- |
About Beijing Scitop Bio Tech Co Ltd
Beijing Scitop Bio-tech Co., Ltd. engages in the research, development, production, and sale of probiotic, postbiotics, and microecological preparations for animals and plants in China. It provides probiotic and postbiotics for gastrointestinal health, immune regulation, oral health, sleep aid and stress relief, women's health, slimming and fat reduction, kidney and liver protection, blood sugar … Read more